The primary aim of this report is to present the results of the 2007 surveillance of surgical site infections (with follow-up data until December 2008) and ICU-acquired infections (with ICU stays until March 2008), and to compare these data with those obtained from 2004 until 2006.

The overall aim of the study is to monitor near real-time performance of COVID-19 vaccines administered as part of 2023 autumnal vaccination campaigns in the community-dwelling resident population aged ≥65 years in EU/EEA countries to detect any variation in VE, so that public health vaccine...

The European Centre for Disease Prevention and Control (ECDC) has developed a monitoring system for hepatitis B and C to support countries in the European Union (EU) and European Economic Area (EEA) in monitoring responses to their epidemics of hepatitis B and C. The monitoring system is closely...

In 2021 and 2022, a survey was developed to assess the impact of COVID-19 on HIV service delivery and monitoring capacity in Europe and Central Asia. Countries were asked whether COVID-19 had an impact on several HIV-specific and non-HIV specific services compared to pre-COVID levels. Although...

Surgical site infections (SSI) are among the most common healthcare-associated infections (HAIs), and are associated with longer post-operative hospital stays, additional surgical procedures, treatment in an intensive care unit, and often higher mortality. All patients undergoing surgery are at...

Narcolepsy is an underdiagnosed disease of widely unknown etiology. This report summarises the results from two epidemiological studies conducted by the Vaccine Adverse Event Surveillance and Communication (VAESCO) Consortium undertaken in eight European Union (EU)/European Economic Area (EEA)...

Surgical site infections are among the most common types of infection. All patients undergoing surgery are at risk of complications, including surgical site infections. The primary aim of this report is to present the results of the 2008-2009 surveillance of surgical site infections across Europe.

This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses (compared to complete primary vaccination with no booster) against hospitalisation due to COVID-19 and COVID-19-related death in resident populations ≥50 years of age living...

This extended report aims to provide a broad overview of the epidemiology and virology of the 2009 pandemic in the European Union and European Economic Area (EU/EEA) countries (27 EU Member States (MS) and Norway and Iceland). Relevant background information on influenza epidemics and pandemics,...